Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Bayer

Showing results (61-70 of 528) with videos related to

Pageof 53
Sort By:
Infection and Immunity|May 24, 2005
A rot mutation restores parental virulence to an agr-null Staphylococcus aureus strain in a rabbit model of endocarditisPeter J McNamara, Arnold S Bayer
Antimicrobial Agents and Chemotherapy|July 1, 1985
Efficacy of BMY-28142 in experimental bacteremia and meningitis caused by Escherichia coli and group B streptococciK S Kim, A S Bayer
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 22, 2008
Cerebrovascular complications in patients with left-sided infective endocarditis: out of site, out of mindLarry M Baddour, Arnold S Bayer
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 28, 2008
Methicillin-resistant Staphylococcus aureus: an evolving clinical challengeAdolf W Karchmer, Arnold S Bayer
The Journal of Infectious Diseases|January 13, 2017
Redeploying β-Lactams Against Staphylococcus aureus: Repurposing With a PurposeArnold S Bayer, Yan Q Xiong
Current Topics in Microbiology and Immunology|August 17, 2006
Antimicrobial peptides versus invasive infectionsM R Yeaman, A S Bayer
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 18, 2021
Prosthetic Valve Endocarditis Diagnosis and Management- New Paradigm Shift NarrativesArnold S Bayer, Henry F Chambers
Chest|July 1, 1993
Progressive pulmonary infiltrates and positive blood cultures for weakly acid-fast, gram-positive rods in a 76-year-old womanD V Moyer, A S Bayer
Nature Biotechnology|February 22, 2005
Programmable ligand-controlled riboregulators of eukaryotic gene expressionTravis S Bayer, Christina D Smolke
Frontiers in Microbiology|June 9, 2012
Engineering microbial consortia to enhance biomining and bioremediationKarl D Brune, Travis S Bayer
Pageof 53

Showing results (61-70 of 528) with videos related to

Sort By:
Pageof 53
Infection and Immunity|May 24, 2005
A rot mutation restores parental virulence to an agr-null Staphylococcus aureus strain in a rabbit model of endocarditisPeter J McNamara, Arnold S Bayer
Antimicrobial Agents and Chemotherapy|July 1, 1985
Efficacy of BMY-28142 in experimental bacteremia and meningitis caused by Escherichia coli and group B streptococciK S Kim, A S Bayer
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 22, 2008
Cerebrovascular complications in patients with left-sided infective endocarditis: out of site, out of mindLarry M Baddour, Arnold S Bayer
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 28, 2008
Methicillin-resistant Staphylococcus aureus: an evolving clinical challengeAdolf W Karchmer, Arnold S Bayer
The Journal of Infectious Diseases|January 13, 2017
Redeploying β-Lactams Against Staphylococcus aureus: Repurposing With a PurposeArnold S Bayer, Yan Q Xiong
Current Topics in Microbiology and Immunology|August 17, 2006
Antimicrobial peptides versus invasive infectionsM R Yeaman, A S Bayer
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 18, 2021
Prosthetic Valve Endocarditis Diagnosis and Management- New Paradigm Shift NarrativesArnold S Bayer, Henry F Chambers
Chest|July 1, 1993
Progressive pulmonary infiltrates and positive blood cultures for weakly acid-fast, gram-positive rods in a 76-year-old womanD V Moyer, A S Bayer
Nature Biotechnology|February 22, 2005
Programmable ligand-controlled riboregulators of eukaryotic gene expressionTravis S Bayer, Christina D Smolke
Frontiers in Microbiology|June 9, 2012
Engineering microbial consortia to enhance biomining and bioremediationKarl D Brune, Travis S Bayer
Pageof 53